Abu-Elmagd K - Search Results

1

Tacrolimus (FK 506)--a new therapeutic agent for severe recalcitrant psoriasis.

Jegasothy BV, Ackerman CD, Todo S, Fung JJ, Abu-Elmagd K, Starzl TE. Jegasothy BV, et al. Arch Dermatol. 1992 Jun;128(6):781-5. Arch Dermatol. 1992. PMID: 1376102 Free PMC article.

2

The question of FK 506 nephrotoxicity after liver transplantation.

McCauley J, Takaya S, Fung J, Tzakis A, Abu-Elmagd K, Jain A, Todo S, Starzl TE. McCauley J, et al. Transplant Proc. 1991 Feb;23(1 Pt 2):1444-7. Transplant Proc. 1991. PMID: 1703344 Free PMC article.

3

Selected topics on FK 506, with special references to rescue of extrahepatic whole organ grafts, transplantation of "forbidden organs," side effects, mechanisms, and practical pharmacokinetics.

Starzl TE, Abu-Elmagd K, Tzakis A, Fung JJ, Porter KA, Todo S. Starzl TE, et al. Transplant Proc. 1991 Feb;23(1 Pt 2):914-9. Transplant Proc. 1991. PMID: 1703351 Review.

4

FK 506 versus cyclosporine in pediatric liver transplantation.

Tzakis AG, Reyes J, Todo S, Green M, Ohya T, Jain A, Abu-Elmagd K, Alessiani M, Fung JJ, Starzl TE. Tzakis AG, et al. Transplant Proc. 1991 Dec;23(6):3010-5. Transplant Proc. 1991. PMID: 1721343 Free PMC article. Clinical Trial. No abstract available.

5

FK 506: a new therapeutic agent for severe recalcitrant psoriasis.

Abu-Elmagd K, Van Thiel D, Jegasothy BV, Ackerman CD, Todo S, Fung JJ, Thomson AW, Starzl TE. Abu-Elmagd K, et al. Transplant Proc. 1991 Dec;23(6):3322-4. Transplant Proc. 1991. PMID: 1721449 No abstract available.

6

Metabolic effects of FK 506 in patients with severe psoriasis: short-term follow-up of seven cases.

Nikolaidis NL, Abu-Elmagd K, Thomson AW, Rilo HR, Irish WD, Van Thiel DH, Fung JJ, Starzl TE. Nikolaidis NL, et al. Transplant Proc. 1991 Dec;23(6):3325-7. Transplant Proc. 1991. PMID: 1721450 Free PMC article. No abstract available.

7

Efficacy of FK 506 in the treatment of recalcitrant pyoderma gangrenosum.

Abu-Elmagd K, Jegasothy BV, Ackerman CD, Thomson AW, Rilo H, Nikolaidis N, Van Thiel D, Fung JJ, Todo S, Starzl TE. Abu-Elmagd K, et al. Transplant Proc. 1991 Dec;23(6):3328-9. Transplant Proc. 1991. PMID: 1721451 Free PMC article. No abstract available.

8

Single-center experience with primary orthotopic liver transplantation with FK 506 immunosuppression.

Todo S, Fung JJ, Starzl TE, Tzakis A, Doyle H, Abu-Elmagd K, Jain A, Selby R, Bronsther O, Marsh W, et al. Todo S, et al. Ann Surg. 1994 Sep;220(3):297-308; discussion 308-9. doi: 10.1097/00000658-199409000-00006. Ann Surg. 1994. PMID: 7522431 Free PMC article. Clinical Trial.

9

Intestinal transplantation in humans under FK 506.

Todo S, Tzakis A, Reyes J, Abu-Elmagd K, Casavilla A, Fung JJ, Starzl TE. Todo S, et al. Transplant Proc. 1993 Feb;25(1 Pt 2):1198-9. Transplant Proc. 1993. PMID: 7680148 Free PMC article. Clinical Trial. No abstract available.

10

Tolerogenic immunosuppression for organ transplantation.

Starzl TE, Murase N, Abu-Elmagd K, Gray EA, Shapiro R, Eghtesad B, Corry RJ, Jordan ML, Fontes P, Gayowski T, Bond G, Scantlebury VP, Potdar S, Randhawa P, Wu T, Zeevi A, Nalesnik MA, Woodward J, Marcos A, Trucco M, Demetris AJ, Fung JJ. Starzl TE, et al. Lancet. 2003 May 3;361(9368):1502-10. doi: 10.1016/s0140-6736(03)13175-3. Lancet. 2003. PMID: 12737859 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

338 results

Search Page